Also, the administration of the drug Tranilast, that suppresses the release of TGF-β by fibroblasts, has been shown to counteract tumor progression in mouse models of C-type lectin domain family 12 member A (CLEC12A/CLL1) Lewis lung cancer and B16F1 melanoma. This evidence concerns the gene CLEC12A and melanoma.